James E.J.E.FramptonJames E.J.E., David H.D.H.PetersDavid H.D.H., Ramipril. An updated review of its therapeutic use in essential hypertension and heart failure, „Drugs”, 49 (3), 1995, s. 440–466, DOI: 10.2165/00003495-199549030-00008, PMID: 7774515(ang.).
S.S.YusufS.S. i inni, Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators, „The New England Journal of Medicine”, 342 (3), 2000, s. 145–153, DOI: 10.1056/NEJM200001203420301, PMID: 10639539(ang.).
James E.J.E.FramptonJames E.J.E., David H.D.H.PetersDavid H.D.H., Ramipril. An updated review of its therapeutic use in essential hypertension and heart failure, „Drugs”, 49 (3), 1995, s. 440–466, DOI: 10.2165/00003495-199549030-00008, PMID: 7774515(ang.).
S.S.YusufS.S. i inni, Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators, „The New England Journal of Medicine”, 342 (3), 2000, s. 145–153, DOI: 10.1056/NEJM200001203420301, PMID: 10639539(ang.).
EwaE.GroszykEwaE. i inni, Leki współczesnej terapii, wyd. XXII, Warszawa: Medical Tribune Polska, 2019, ISBN 978-83-951310-6-6, OCLC1150526325 [dostęp 2021-02-22]. Brak numerów stron w książce